Vijay R. Nadipelli

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Barbara R. Haight, Susan M. Learned, Céline M. Laffont et al. · The Lancet · 2019 · 268 citations

Opioid Epidemic, Substance Use, Psychiatry +7

Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder

Naoko Ronquest, Tina M. Willson, Leslie Montejano et al. · Substance Abuse and Rehabilitation · 2018 · 100 citations · Full text

Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system

Joseph A. Boscarino, H. Lester Kirchner, James Pitcavage et al. · Substance Abuse and Rehabilitation · 2016 · 65 citations · Full text

Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term study

Walter Ling, Vijay R. Nadipelli, Caitlyn T. Solem et al. · Journal of Substance Abuse Treatment · 2019 · 54 citations · Full text

Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study

Walter Ling, Vijay R. Nadipelli, Arnie Aldridge et al. · Journal of Addiction Medicine · 2020 · 52 citations · Full text